NA
DERM icon

NewEdge Advisors’s Journey Medical DERM Stock Holding History

NewEdge Advisors’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,124
Closed -$7.82K – 3844
2024
Q1 		$7.82K Sell
2,124
-34,468
-94% -$150K ﹤0.01% 2981
2023
Q4 		$202K Buy
36,592
+24,348
+199% +$108K ﹤0.01% 1711
2023
Q3 		$33.5K Buy
+12,244
New +$27.4K ﹤0.01% 2220

Other funds holding DERM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NewEdge Advisors's DERM Position: Q2 2024 in Review

NewEdge Advisors sold out of Journey Medical (DERM) in Q2 2024, closing a stake of 2,124 shares — an estimated $7.82K sold.

NewEdge Advisors first reported a position in DERM in Q3 2023 and held it in 3 quarters. The position peaked at $202K in Q4 2023. 35 funds tracked by Wall St. Rank hold DERM as of Q2 2024.

  • NewEdge Advisors reported no remaining Journey Medical position as of Q2 2024 after selling out during the quarter.
  • NewEdge Advisors sold 2,124 Journey Medical shares in Q2 2024, an estimated $7.82K.
  • NewEdge Advisors first reported a position in Journey Medical in Q3 2023 and held it in 3 quarters.
  • NewEdge Advisors's Journey Medical position peaked at $202K in Q4 2023.
  • 35 funds tracked by Wall St. Rank held Journey Medical as of Q2 2024.

Based on NewEdge Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.